<DOC>
	<DOCNO>NCT01457716</DOCNO>
	<brief_summary>The aim study ass compare Pharmacokinetic ( PK ) Budesonide Formoterol administration 3 different product variant Budesonide/Formoterol Easyhalers Symbicort turbuhaler .</brief_summary>
	<brief_title>Pharmacokinetic Pilot Study Budesonide/Formoterol</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Healthy male female , 1855 year age . Normal weight least 50 kg . Evidence clinically significant cardiovascular , renal , hepatic , haematological , gastrointestinal , pulmonary , metabolicendocrine , neurological psychiatric disease . Any condition require concomitant treatment ( include vitamin herbal product ) likely need concomitant treatment study Any clinically significant abnormal laboratory value physical finding may interfere interpretation test result cause health risk subject he/she participates study . Known hypersensitivity active substance ( ) excipients drug . Pregnant lactating female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>